🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseEfinopegdutide MASH data — July 2024 Page 3

Efinopegdutide MASH data — July 2024

KarenAZ_mom Thu, May 30, 2024 at 2:14 PM 39 replies 2,830 viewsPage 3 of 8
LipidDoc_ATL
Senior Member
1,123
5,678
Apr 2024
Atlanta, GA
Jun 2, 2024 at 7:34 AM#11
sean_dublin said:
The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either.

No disagreement, though the timescale matters more than the mechanism here. Most of what looks like a difference in kind turns out to be a difference in how long somebody waited.

47 20rachel_ABQ, traveltech_sara, AttorneyGrant and 44 others
Reply Quote Save Share Report
WendyG_ATL
Member
1,023
5,678
Apr 2024
Georgia
Jun 3, 2024 at 2:04 PM#12
mike_nyc said:
Liver imaging follow-up for liver and MASH: FibroScan at baseline showed CAP score 325 dB/m (moderate steatosis) and stiffness 9.8 kPa (possible…

Bookmarking. The distinction being drawn above is the one nobody else makes. Adding it to my notes with a link back to this thread.

48 21rachel_ABQ, traveltech_sara, AttorneyGrant and 45 others
Reply Quote Save Share Report
BrianDallas92
Member
312
1,456
Oct 2024
Dallas, TX
Jun 4, 2024 at 8:33 PM#13
sean_dublin said:
The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either.

Worth saying that the confident version of this is more useful to the person writing it than to the person reading it.

I would rather be corrected than agreed with, if it comes to it.

Last edited: Jun 4, 2024 at 9:33 PM
49 22andrew_nyc, Dr.EndoEP, GraceAZ_72 and 46 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
anders_CPH
Senior Member
1,567
7,234
Feb 2024
Copenhagen, DK
Jun 6, 2024 at 3:02 AM#14

The figures, for anyone assembling their own picture. If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way. Most of the apparent contradictions in these threads dissolve at that step.

50 23BethLabQueen, ChrisMacros, KetoKyle and 47 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Jun 7, 2024 at 9:30 AM#15

Moderator note: a couple of off-topic posts removed.

1 24PeptideSynthNJ
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register